Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Broadly Neutralizing Antibodies
100%
Rational Design of Vaccines
100%
Monoclonal Antibody
33%
HIV Patients
33%
Immunogen
33%
Virus
33%
Recognition Site
33%
Vaccine Candidate
33%
Neutralizing Antibodies
33%
Highly Effective
33%
Circulating Strains
33%
HIV-1 Env
33%
Protective Antibodies
33%
AIDS Vaccine
33%
Strain Specificity
33%
Natural Infection
33%
Development Pathways
33%
Broadly Protective
33%
Non-neutralizing
33%
Immunology and Microbiology
Vaccine Efficacy
100%
Human Immunodeficiency Virus 1
100%
Neutralizing Antibody
100%
Monoclonal Antibody
66%
Monospecific Antibody
66%
Human Immunodeficiency Virus
66%
Antibody Response
33%
Antigen
33%
HIV Vaccine
33%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
100%
Neutralizing Antibody
100%
Monospecific Antibody
66%
Human Immunodeficiency Virus
66%
Monoclonal Antibody
66%
Antibody Response
33%